Peter Van Dam emeritus occasional assignment

Publications Peter Van Dam

Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial

Source
Frontiers in immunology - ISSN 1664-3224-17 (2026) p.
Author(s)
    Regina Esi Mensimah Baiden-Amissah, Sandra Tuyaerts, Daniela Annibali, Alejandro Herreros-Pomares, Wout De Wispelaere, Rossana Maria Benedetto, Emiel A. De Jaeghere, An M.T. Van Nuffel, Peter Vuylsteke, Stephanie Henry, Xuan Bich Trinh, Peter André Van Dam, Sandrine Aspeslagh, Alex De Caluwe, Eline Naert, Katrien Vandecasteele, Hannelore G. Denys, Frederic Amant

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns

Source
Cancer immunology and immunotherapy - ISSN 0340-7004-75:4 (2026) p. 1-17
Author(s)

Locally advanced breast cancers : the EUSOMA experience

Source
European journal of surgical oncology - ISSN 0748-7983-52:3 (2026) p. 1-8
Author(s)
    Peter André Van Dam, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Julie Verhaegen, Cynthia Aristei, Maria Joao Cardoso, Kwok Leung Cheung, Giuseppe Curigliano, Jakob De Vries, Donatella Santini, Francesco Sardanelli, Isabel T. Rubio

Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over : insights from the EUSOMA database

Source
European journal of cancer - ISSN 0959-8049-236 (2026) p. 1-8
Author(s)
    Cynthia Aristei, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Niccolo M.L. Battisti, Kwok Leung Cheung, Olaf J. Hartmann, Isabel T. Rubio, Donatella Santini, Francesco Sardanelli, Elzbieta Senkus, Peter André Van Dam, Giuseppe Curigliano

The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology

Source
Breast cancer research - ISSN 1465-5411-28:1 (2026) p. 1-19
Author(s)